Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Barriers and Facilitators of Flu, Pneumonia and SARS-CoV-2 (COVID-19) Vaccination in Adults With Inflammatory Conditions Treated With Immune-suppressing Drugs

NCT05115370 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT05115370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05115370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Barriers and Facilitators of Flu, Pneumonia and SARS-CoV-2 (COVID-19) Vaccination in Adults With Inflammatory Conditions Treated With Immune-suppressing Drugs
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Completed
Start date
November 1, 2021
Completion date
January 14, 2022
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, inflammatory bowel diseases, inflammatory disease, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, systemic lupus erythematosus, vasculitis